#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Alcohol Harm Reduction: Corporate Capture of a Key Concept


article has not abstract


Vyšlo v časopise: Alcohol Harm Reduction: Corporate Capture of a Key Concept. PLoS Med 11(12): e32767. doi:10.1371/journal.pmed.1001767
Kategorie: Policy Forum
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001767

Souhrn

article has not abstract


Zdroje

1. Prime Minister's Strategy Unit (2004) Alcohol harm reduction strategy for England. London: Prime Minister's Strategy Unit.

2. RoomR (2004) Disabling the public interest: alcohol strategies and policies for England. Addiction 99: 1083–1089.

3. DrummondDC (2004) An alcohol strategy for England: the good, the bad and the ugly. Alcohol Alcohol 39: 377–379.

4. MarmotMG (2004) Evidence based policy or policy based evidence? BMJ 328: 906–907.

5. Alcohol Concern (2014) Statistics on alcohol. Available: http://www.alcoholconcern.org.uk/wp-content/uploads/2014/09/Summary-of-alcohol-statistics.pdf. Accessed 12 November 2014.

6. Davies SC (2012) Annual report of the Chief Medical Officer, Volume 1, 2011: on the state of the public's health. London: Department of Health.

7. Secretary of State for the Home Department (2012) The government's alcohol strategy. Cm 8336. London: The Stationery Office. Available: http://www.homeoffice.gov.uk/publications/alcohol-drugs/alcohol/alcohol-strategy?view=Binary. Accessed 5 November 2014.

8. McCambridgeJ (2012) Dealing responsibly with the alcohol industry in London. Alcohol Alcohol 47: 635–637.

9. GodleeF (2014) Minimum alcohol pricing: a shameful episode. BMJ 348: g110 doi:10.1136/bmj.g110

10. McCambridgeJ (2012) A user's guide to the 2012 Alcohol Strategy for England and Wales: a commentary on the commentaries. Drugs (Abingdon Engl) 19: 377–378.

11. McCambridgeJ, HawkinsB, HoldenC (2014) Vested interests in addiction research and policy. The challenge corporate lobbying poses to reducing society's alcohol problems: insights from UK evidence on minimum unit pricing. Addiction 109: 199–205.

12. HoldenC, HawkinsB (2013) ‘Whisky gloss’: the alcohol industry, devolution and policy communities in Scotland. Public Policy Adm 28: 253–273.

13. KatikireddiSV, HiltonS, BonellC, BondL (2014) Understanding the development of minimum unit pricing of alcohol in Scotland: a qualitative study of the policy process. PLoS ONE 9: e91185.

14. BBC News (2014 Apr 30) Minimum alcohol policy referred to European court. Available: http://www.bbc.co.uk/news/uk-scotland-scotland-politics-27219905. Accessed 5 November 2014.

15. McGrady B (2012) Confronting the tobacco epidemic in a new era of trade and investment liberalization. Geneva: World Health Organization.

16. World Health Organization (2014) Global status report on alcohol and health 2014. Available: http://www.who.int/substance_abuse/publications/global_alcohol_report/en/. Accessed 5 November 2014.

17. WhiteIR, AltmannDR, NanchahalK (2002) Alcohol consumption and mortality: modelling risks for men and women at different ages. BMJ 325: 191.

18. Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht N, et al. (2010) Alcohol: no ordinary commodity—research and public policy, 2nd edition. Oxford: Oxford University Press.

19. McCambridgeJ, HartwellG (2014) Has industry funding biased studies of the protective effects of alcohol on cardiovascular disease? A preliminary investigation of prospective cohort studies. Drug Alcohol Rev E-pub ahead of print. doi:10.1111/dar.12125

20. RoereckeM, RehmJ (2012) The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction 107: 1246–1260.

21. FekjaerHO (2013) Alcohol—a universal preventive agent? A critical analysis. Addiction 108: 2051–2057.

22. FillmoreKM, StockwellT, ChikritzhsT, BostromA, KerrW (2007) Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses. Ann Epidemiol 17 (Suppl 5) S16–S23.

23. Ng FatL, CableN, MarmotMG, SheltonN (2014) Persistent long-standing illness and non-drinking over time, implications for the use of lifetime abstainers as a control group. J Epidemiol Community Health 68: 71–77.

24. HolmesMV, DaleCE, ZuccoloL, SilverwoodRJ, GuoY, et al. (2014) Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 349: g4164.

25. Rose G (1992) The strategy of preventive medicine. Oxford: Oxford University Press.

26. NavarroHJ, ShakeshaftA, DoranCM, PetrieDJ (2013) Does increasing community and liquor licensees' awareness, police activity, and feedback reduce alcohol-related violent crime? A benefit-cost analysis. Int J Environ Res Public Health 10: 5490–5506.

27. StrangJ, OrgelM, FarrellM (1989) Well users clinic for illicit drug users. BMJ 298: 1310.

28. StimsonGV (1996) Has the United Kingdom averted an epidemic of HIV-1 infection among drug injectors? Addiction 91: 1085–1088.

29. Harm Reduction International (2014) What is harm reduction? A position statement from Harm Reduction International. Available: http://www.ihra.net/what-is-harm-reduction. Accessed 5 November 2014.

30. HuntN (2004) Public health or human rights: what comes first? Int J Drug Policy 15: 231–237.

31. Room R (2010) The ambiguity of harm reduction—goal or means, and what constitutes harm? In: Rhodes T, Hedrich D, editors. Harm reduction: evidence, impacts and challenges. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. pp. 108–114.

32. RoomR (2004) Alcohol and harm reduction, then and now. Crit Public Health 14: 329–344.

33. Plant M, Single E, Stockwell T, editors(1997) Alcohol: minimising the harm. What works? London: Free Association Books.

34. StockwellT (2006) Alcohol supply, demand, and harm reduction: what is the strongest cocktail? Int J Drug Policy 17: 269–277.

35. MarlattGA, WitkiewitzK (2002) Harm reduction approaches to alcohol use: health promotion, prevention, and treatment. Addict Behav 27: 867–886.

36. StrangJ (1992) Harm reduction for drug users: exploring the dimensions of harm, their measurement, and strategies for reduction. AIDS Public Policy J 7: 145–152.

37. ObotIS (2007) Harm reduction: what is it? Addiction 102: 691.

38. HallW (2007) What's in a name? Addiction 102: 692.

39. WeatherburnD (2009) Dilemmas in harm minimization. Addiction 104: 335–339.

40. JerniganDH (2012) Global alcohol producers, science, and policy: the case of the International Center for Alcohol Policies. Am J Public Health 102: 80–89.

41. Stimson G (2013) Harm reduction for drugs, alcohol and tobacco. 5th International Conference on Alcohol Harm Reduction; 7–8 Mar 2013; Frankfurt am Main, Germany.

42. StimsonGV (2013) The future of global health is urban health. Lancet 382: 1475.

43. CaetanoR (2008) The alcohol industry's smoke and mirrors. Addiction 103: 1231–1232.

44. MillerD, HarkinsC (2010) Corporate strategy, corporate capture: food and alcohol industry lobbying and public health. Crit Soc Policy 30: 564–589.

45. HawkinsB, McCambridgeJ (2014) Industry actors, think tanks and UK alcohol policy. Am J Public Health 104: 1363–1369.

46. Michaels D (2008) Doubt is their product: how industry's assault on science threatens your health. Oxford: Oxford University Press.

47. Oreskes N, Conway EM (2010) Merchants of doubt: how a handful of scientists obscured the truth on issues from tobacco smoke to global warming. London: Bloomsbury Press.

48. McCambridgeJ, HawkinsB, HoldenC (2013) Industry use of evidence to influence alcohol policy: a case study of submissions to the 2008 Scottish government consultation. PLoS Med 10: e1001431.

49. McGarity TO, Wagner WE (2012) Bending science: how special interests corrupt public health research. Cambridge (Massachusetts): Harvard University Press.

50. Smith KE (2013) Beyond evidence based policy in public health: the interplay of ideas. Basingstoke (UK): Palgrave Macmillan.

51. AdamsPJ, BuetowS, RossenF (2010) Vested interests in addiction research and policy. Poisonous partnerships: health sector buy-in to arrangements with government and addictive consumption industries. Addiction 105: 585–590.

52. BaborTF, RobainaK (2013) Public health, academic medicine, and the alcohol industry's corporate social responsibility activities. Am J Public Health 103: 206–214.

53. McCreanorT, CasswellS, HillL (2000) ICAP and the perils of partnership. Addiction 95: 179–185.

54. BaborT, HallW, HumphreysK, MillerP, PetryN, et al. (2013) Who is responsible for the public's health? The role of the alcohol industry in the WHO global strategy to reduce the harmful use of alcohol. Addiction 108: 2045–2047.

55. BarbourV, ClarkJ, JonesS, NortonM, VeitchE (2011) Let's be straight up about the alcohol industry. PLoS Med 8: e1001041.

56. CasswellS (2013) Vested interests in addiction research and policy. Why do we not see the corporate interests of the alcohol industry as clearly as we see those of the tobacco industry? Addiction 108: 680–685.

57. World Health Organization (2010) Global strategy to reduce the harmful use of alcohol. Geneva: World Health Organization.

58. ChanM (2013) Rapid response. Re: Doctors and the alcohol industry: an unhealthy mix? BMJ 346: f1889 Available: http://www.bmj.com/content/346/bmj.f1889/rapid-responses. Accessed 5 November 2014.

59. DaubeM (2012) Alcohol and tobacco. Aust N Z J Public Health 36: 108–110.

60. Stimson G, Grant M, Choquet M, Garrison P (2007) Drinking in context: patterns, interventions, and partnerships. New York: Routledge.

61. FarrellM (2007) The alcohol industry: taking on the public health critics. BMJ 335: 671 doi:10.1136/bmj.39337.431667.4E

62. International Center for Alcohol Policies (2014) Leading producers of beer, wine and spirits announce new global organization: new organization will build on historic efforts to help reduce harmful drinking. Available: http://www.icap.org/LinkClick.aspx?fileticket=5P5NPGKxUQg%3d&tabid=36. Accessed 5 November 2014.

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2014 Číslo 12
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#